Top stocks in focus: Lupin, Fortis, Bank of Maharashtra, HDFC Bank

Lupin gets USFDA approval for Clobazam Oral Suspension.

Fortis Healthcare's board approved an extension of the long stop date under the Master Purchase Agreement to March 26.

Bank of Maharashtra received equity capital of Rs4,498cr from the government.

HDFC Bank increased lending rates by 10bps.

Central Bank of India and UCO Bank have received Rs1,678cr and Rs3,076cr respectively, by making a preferential allotment of shares to the government.

JMC Projects bagged an order worth Rs596cr

Centrum Capital’s arm acquired supply chain finance business of L&T Finance.

KEC International and Adani Transmission mutually agreed to extend the date of sale to Jan 31.

Allahabad Bank revised MCLR by 10 basis points across various tenors.

CreditAccess Grameen has completed a direct assignment of Rs277.73cr and securitization transaction of Rs110.5cr.

Shriram Transport Finance would consider raising fund via debt during the month of January.

IL&FS puts commercial, residential properties up for sale.

Today Intraday Future Tips